Endovia Health Sciences (EDVA) Other Operating Expenses (2013 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Other Operating Expenses (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.44 Bn | 133.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.65 Bn | 78.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.10 Bn | 59.92 Bn | 1.37 Bn |
| 4 | Moderna | 57.10 Bn | 51.97 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.13 Bn | 27.30 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 963,545.00 |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 9.54 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | -367,559.00 |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 3.63 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 3.40 Mn |
| Jun 30, 2022 | 4.23 Mn |
| Mar 31, 2022 | 3.57 Mn |
| Dec 31, 2021 | 7.51 Mn |
| Sep 30, 2021 | 12.64 Mn |